Modulation of COX2 and hTERT expression by photodynamic therapy in human colon cancer cells
暂无分享,去创建一个
[1] T. Vogl,et al. A multicenter Phase I safety study of intratumoral photoactivation of talaporfin sodium in patients with refractory solid tumors , 2003, Cancer.
[2] R. DuBois,et al. COX-2: a molecular target for colorectal cancer prevention. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] I Vergote,et al. A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group. , 1997, Journal of clinical pathology.
[4] N. Mak,et al. Cellular uptake, subcellular localization and photodamaging effect of temoporfin (mTHPC) in nasopharyngeal carcinoma cells: comparison with hematoporphyrin derivative. , 2000, Cancer letters.
[5] T. Albertson,et al. Pharmacokinetics and clinical effects of mono‐l‐aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces , 2005, Photodermatology, photoimmunology & photomedicine.
[6] T. Kaneko,et al. Detection of photodynamic therapy-induced early apoptosis in human salivary gland tumor cells in vitro and in a mouse tumor model. , 2004, Oral oncology.
[7] T. Wieman,et al. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] D. Kessel,et al. DETERMINANTS OF PHOTOSENSITIZATION BY MONO‐L‐ASPARTYL CHLORIN e6 , 1989, Photochemistry and photobiology.
[9] R. Ho,et al. Effects of photoactivated 5-aminolevulinic acid hexyl ester on MDR1 over-expressing human uterine sarcoma cells. , 2008, Toxicology letters.
[10] C. Gomer,et al. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. , 2002, Cancer research.
[11] D. Kessel,et al. Determinants of the Apoptotic Response to Lysosomal Photodamage , 2000, Photochemistry and photobiology.
[12] J. Prehn,et al. Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: a review. , 2009, Biochimica et biophysica acta.
[13] Hiroshi Nakamura,et al. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines , 2002, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[14] A. Kato,et al. Review article: COX-2, prostanoids and colon cancer. , 2002, Alimentary pharmacology & therapeutics.
[15] M W Berns,et al. In vitro photosensitization I. Cellular uptake and subcellular localization of mono‐L‐aspartyl chlorin e6, chloro‐aluminum sulfonated phthalocyanine, and photofrin II , 1989, Lasers in surgery and medicine.
[16] Zheng Huang,et al. Combination of Photodynamic Therapy and Immunomodulation: Current Status and Future Trends , 2008 .
[17] J. Metz,et al. Endobronchial photodynamic therapy for the treatment of lung cancer. , 2001, Chest surgery clinics of North America.
[18] A. Grothey. Biological Therapy and Other Novel Therapies in Early-Stage Disease: Are They Appropriate? , 2007, Clinical Cancer Research.
[19] Maohui Luo,et al. The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer. , 2007, European journal of obstetrics, gynecology, and reproductive biology.
[20] C. M. Yow,et al. Photodynamic effect in medulloblastoma: downregulation of matrix metalloproteinases and human telomerase reverse transcriptase expressions , 2008, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[21] L. Kèlland,et al. Telomerase: biology and phase I trials. , 2001, The Lancet. Oncology.
[22] J. Usuda,et al. Photodynamic therapy (PDT) for lung cancers. , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[23] R. Demir,et al. Ultrastructural and immunohistochemical analysis of rat uroepithelial cell junctions after partial bladder outlet obstruction and selective COX-2 inhibitor treatment. , 2006, Acta histochemica.
[24] C J Gomer,et al. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model. , 1992, Cancer research.
[25] Thomas J. Dougherty,et al. Basic principles of photodynamic therapy , 2001 .
[26] K. Imai,et al. Increased cyclooxygenase-2 expression in large flat colorectal tumors (laterally spreading tumors) , 2003, Journal of Gastroenterology.
[27] Q. Qi,et al. Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells. , 2006, Life sciences.
[28] C. Gomer,et al. CHOP activation by photodynamic therapy increases treatment induced photosensitization , 2004, Lasers in surgery and medicine.
[29] A. Zinsmeister,et al. Mono‐L‐aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model , 1998, Cancer.